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Abstract: Intrinsic factors of the innate immune system include the apolipoprotein B editing
enzyme catalytic polypeptide-like 3 (APOBEC3) protein family. APOBEC3 inhibits replication of
different virus families by cytosine deamination of viral DNA and a not fully characterized cytosine
deamination-independent mechanism. Sheep are susceptible to small ruminant lentivirus (SRLVs)
infection and contain three APOBEC3 genes encoding four proteins (A3Z1, Z2, Z3 and Z2-Z3) with
yet not deeply described antiviral properties. Using sheep blood monocytes and in vitro-derived
macrophages, we found that A3Z1 expression is associated with lower viral replication in this
cellular type. A3Z1 transcripts may also contain spliced variants (A3Z1Tr) lacking the cytidine
deaminase motif. A3Z1 exogenous expression in fully permissive fibroblast-like cells restricted SRLVs
infection while A3Z1Tr allowed infection. A3Z1Tr was induced after SRLVs infection or stimulation of
blood-derived macrophages with interferon gamma (IFN-γ). Interaction between truncated isoform
and native A3Z1 protein was detected as well as incorporation of both proteins into virions. A3Z1
and A3Z1Tr interacted with SRLVs Vif, but this interaction was not associated with degradative
properties. Similar A3Z1 truncated isoforms were also present in human and monkey cells suggesting
a conserved alternative splicing regulation in primates. A3Z1-mediated retroviral restriction could be
constrained by different means, including gene expression and specific alternative splicing regulation,
leading to truncated protein isoforms lacking a cytidine-deaminase motif.
Keywords: APOBEC3; small ruminant lentiviruses; restriction factors; deaminase domain;
alternative splicing
1. Introduction
Apolipoprotein B editing enzyme catalytic polypeptide-like 3 (APOBEC3; A3) proteins are
cytidine deaminases capable of inhibiting replication of several retroviruses, DNA viruses, long
terminal repeat (LTR) and non-LTR retroelements, and even eliminate experimentally transfected
plasmid DNA [1]. The A3 family contains seven paralogs in humans (A3A-A3H) and is part of the
activation-induced cytidine deaminase-AID/APOBEC gene family, which shares the characteristic zinc
(Zn2+)-coordinating catalytic motif (His-X-Glu-X23-28-Pro-Cys-X2-4-Cys). Each A3 protein contains
one or two Z-coordinating motif-containing domains, giving rise to a new classification based on the
quantity and quality of the Z domains [2].
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The complete picture of A3-mediated viral restriction mechanism is dependent on the targeted
virus and not fully understood. Regarding lentiviruses, A3 main activity is to mutate nascent lentiviral
cDNA after the clearance of RNA from the DNA/RNA hybrid. Such mutations generate highly
deaminated non-functioning viral genomes that can be processed by the cellular DNA repairing
system. A3 incorporated into virions (passenger A3) is the main cause of deamination evidenced by
viral reverse transcripts displaying a high frequency of G-A mutations. However, A3G, A3F and A3A
have also been shown to reduce virus infectivity in a cytosine-deaminase independent manner [3,4].
Several studies have found signatures of A3 editing activity on retroviral genomes clearly
demonstrating that A3 proteins edit lentiviral DNA in vivo [5]. Among them, A3G and A3F have been
the most studied due to both high antiviral activity in vitro and high expression levels in human T
cells. A3A with a single Z1 motif has a negligible antiviral activity against human immunodeficiency
virus (HIV-1) in vitro [6]. However, A3A is involved in the antiviral state of lentivirus target cells such
as monocyte/macrophages or dendritic cells with proven antiviral activity in vivo [7].
The protein in small ruminants homologous to human A3A is called A3Z1. A3Z1 induction in
ovine and caprine blood-derived macrophages is achieved upon treatment with interferon (IFN-γ)
and has been proposed as a marker of the M1 profile of macrophage differentiation which is in turn,
able to restrict HIV-1 and Small Ruminant Lentiviruses (SRLVs) replication at a post-entry step [8,9].
SRLV are present all over the world in sheep, goats and wild ungulates and cause a multisystemic
disease exerting meningoencephalitis, arthritis, pneumonitis and/or mastitis [10,11]. SRLVs main
target cells are from the monocyte/macrophage lineage but monocytes restrict viral replication until
they differentiate into tissue macrophages, in which viral replication and protein expression are
induced [12]. Besides the required gag, pol and env genes, SRLVs encode a series of accessory genes
such as vif, tat or vpr-like and rev [13]. Among them, the accessory protein Vif has been extensively
studied as the main A3 antagonist. HIV-1 Vif expression counteracts the hA3 antiviral effect by targeting
the protein for degradation by the proteasome, preventing its incorporation into the virion [14–16].
SRLVs Vif can mediate degradation of sheep A3Z3 and A3Z3 orthologs in humans, macaques, cows
and cats [17].
Sheep encode four functionally active A3 proteins (Z1, Z2, Z3 and Z2Z3) [18], whose cytosine
deaminase enzymatic activity is not required for full levels of retrovirus restriction [19]. Artiodactyl
A3Z2Z3 proteins, besides being fully resistant to HIV-1 Vif activity, have shown a broad antiviral
restriction against HIV-1 and Murine Leukemia Virus (MLV) inhibiting their infectivity by 8 and 4-fold
respectively [19].
In this study, we have explored A3 expression in the ovine monocyte to macrophage maturation
process and its influence on SRLVs replication. A3Z1 downregulation (and not A3Z2, Z3 or Z2Z3)
correlated with increased SRLVs viral replication in monocyte-derived and M2-polarized macrophages.
In contrast, high A3Z1 expression levels correlate with SRLVs virus restriction in monocytes and
M1-macrophages. Besides the full protein, additional A3Z1 truncated protein forms lacking the cytidine
deaminase motif (A3Z1Tr) were detected following immune stimulation with IFN-γ, interleukin 4
(IL-4) or infection with SRLVs. Both proteins were efficiently incorporated into virions but restriction
was only exerted by A3Z1, and was independent of viral Vif, despite protein-protein interaction.
2. Materials and Methods
This project has been approved by the local Ethics Committee for the use of animal samples
from the University of Zaragoza (Government of Aragon), reference number PI15/14, project
AGL2013-49137-C3-R (2014–2017). Requirements of the Spanish (RED53/2013) and the European
Union (2010/63) animal protection policies were fulfilled.
2.1. Samples and Cells
Lung samples were collected in RNAlater buffer (Qiagen, Hilden, Germany) at necropsy from two
sheep of the Rasa Aragonesa and Assaf breeds after euthanasia by intravenous injection of barbiturate
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overdose followed by exsanguination. For the caprine counterpart, peripheral blood mononuclear cells
(PBMC) were isolated from ethylenediaminetetraacetic acid (EDTA)-blood by Lymphoprep gradient
centrifugation (δ = 1.077; Asix-Shield, Oslo, Norway) from one Murciano-Granadina goat.
PBMCs from SRLVs-free Rasa Aragonesa sheep, checked by serology and PCR, were seeded in two
wells at 106 cells/well in 6-well plates and monocytes were isolated by adherence in RPMI complete
medium (1% of vitamins, 10 mM sodium pyruvate, 1% non-essential amino acids, 1% L-glutamine,
50 µM β-mercaptoethanol, 1% antibiotics/antimycotics mix). One replica was kept in TRI Reagent®
(Invitrogen, Carlsbad, CA, USA) after three days of culture (monocytes) for further RNA extraction.
Another replica was allowed to differentiate into blood-derived macrophages (BDM) for twelve days of
culture in RPMI complete medium supplemented with 10% fetal bovine serum (FBS). BDM maturation
using IFN-γ and IL-4, hallmark cytokines of the M1 and M2 profiles respectively, was also carried
out as previously described [8]. BDMs were collected for RNA extraction and RT-PCR was carried
out using specific primers for M1 (APOBEC3Z1, A3Z1) and M2 markers (Mannose Receptor, MR;
and Specific Intercellular adhesion molecule-3-Grabbing Non-integrin, DC-SIGN), and for A3Z1 and
A3Z1Tr quantification (Table 1).
Table 1. Primer pairs used.
Name Sequence Localization Amplicon Size(nt) Reference
A3Z1-Out-Fw AGGACTCGGAGCCAGGGACGA Z1 3′-UTR
621 This work
A3Z1-Out-Rv TCCTGCCATCTTAGAGAGGCTG Z1 5′-UTR
A3A-Hs-Fw ATGGAAGCCAGCCCAGCATC A3A met
600 This work
A3A-Hs-Rv TCAGTTTCCCTGATTCTGGAG A3A stop
qA3Z1-Fw TCCGTTCTTGGAATCTGGAC Z1 CDS
151 [8]
qA3Z1-Rv GTATAGATGCGGGAGGCAAA Z1 CDS
qA3Z2-Fw TTGAACCACCCTGTCTTTCC Z2 3′-UTR
188 This work
qA3Z2-Rv CAGGCTTCAGGGTTGTTGTT Z2 3′-UTR
qA3Z3-Fw GGGCGAGGAGATTGTGTTT Z3 CDS
182 This work
qA3Z3-Rv AAGCAGCCTTTGTCAAGCAT Z3 CDS
qA3Z2-Z3-Fw CAGGCCTTGGAAGAAACTGA Z2 CDS
151 This work
qA3Z2-Z3-Rv CCTCCGGTAGTAAGGTGGTG Z3 CDS
qA3Z1Tr-Fw3 GCTTTGTGCGCAACAAGAAA Z1 CDS 85 This work
MR qPCR-Fw TGGCAAATCCAGTTGTTAAGATGTT MR CDS
MR qPCR-Rv AGAATGTTGAATACTGTGGCGAGTT MR CDS 91 [8]
DC-SIGN-Fw GGTTCCGGAGTCTGACTGAAGTT DC CDS
DC-SIGN-Rv GGTCAGGCGCTGTAGGATCTC DC CDS 73 [8]
β-actin-Fw CTCACGGAGCGTGGCTACA Actin CDS
β-actin-Rv GCCATCTCCTGCTCGAAGTC Actin CDS 88 [8]
A3Z1-EcoRI-Fw TTTGAATTCGCCACCATGGATGAAAACACCTTCACTG Z1 met
588 This work
A3Z1-XhoI-Rv TTTCTCGAGCTACTATCAGTTTTGCTGAGCCCTGA Z1 stop
LTR-Fw TGACACAGCAAATGTAACCGCAA LTR
5126 This work
SP33-Rv CTTCCCCTTCCCAGAGTACCTGAG POL
CDS: Coding DNA sequence; UTR: Untranslated region; Sequences are listed 5′ to 3′; Restriction enzyme recognition
sites are underlined. Hs: Hommo sapiens. MR: Mannose Receptor. DC-SIGN: Specific Intercellular adhesion
molecule-3-Grabbing Non-integrin. LTR: long terminal repeat. POL: SRLV pol gene.
Human embryonic kidney (HEK)-293T cell, T-immortalized goat embryo fibroblast cell line TIGEF
(kindly provided by Dr. Yahia Chebloune), and ovine skin fibroblast OSF, were used for propagation
of viral stocks and/or for restriction studies in vitro.
PBMCs from four human samples, isolated from a dialysis filter, and two from different
Cynomolgus Monkeys were kindly provided by Dr. Sandra Hervás (CIMA, Pamplona, Spain).
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2.2. RNA Extraction and cDNA Synthesis
Tissue samples (10 mg) were homogenized in a Micro-Dismembrator U using steel beads (Sartorius,
Göttingen, Germany). Total RNA isolation from PBMC, BDM and lung samples was performed by
chloroform extraction and isopropanol precipitation. RNA was treated with TurboDNaseI (Invitrogen,
Carlsbad, CA, USA) and purified by extraction with phenol acid, chloroform, and ethanol precipitation.
Total RNA (1 µg) was retrotranscribed to cDNA with Transcriptor First Strand cDNA Synthesis (Roche,
Basel, Switzerland) using oligo-dT primers.
2.3. Viral Stocks
SRLVs viral stocks from the genotype A (strain EV1, Maedi Visna virus-MVV-like) [20] and from
the genotype B (strain 496, Caprine Arthritis Encephalitis virus-CAEV-like) [21] both from ovine origin,
were titrated on permissive skin fibroblasts in 96-well tissue culture plates by using the Reed-Muench
method after 7 days of infection and used in in vitro infections as specified.
2.4. Amplification of Complete A3Z1/A3A and Sequence Analysis
Primers were designed outside the A3Z1 coding region targeting the 5′ and 3′-UTRs (A3Z1-Out-Fw
and A3Z1-Out-Rv; Table 1) in order to amplify the complete ovine sequences. cDNAs were from lung
samples of Rasa Aragonesa and Assaf sheep breeds and from PBMC of a Murciano-Granadina goat.
PCR reactions were performed with the PhusionTM High Fidelity Polymerase (Thermo Scientific,
Waltham, MA, USA); amplicons were cloned into Topo-Blunt plasmid (Invitrogen, Carlsbad, CA, USA)
following manufacturer’s instructions and sequenced (Stab Vida, Caparica, Portugal).
Human and monkey A3A complete coding regions were amplified with PhusionTM High Fidelity
Polymerase using primers based on GenBank sequences (A3A-Hs-Fw and A3A-Hs-Rv; Hs-Hommo
sapiens. Table 1). Amplified fragments were cloned into pJET vector (Thermo Scientific) and sequenced.
Nucleotide and deduced amino acid sequences obtained were aligned with the ClustalX program
(University College Dublin, Belfield, Dublin, Ireland). Protein domains, families and functional sites
were deduced using ScanProsite tool (ExPASy, SIB Swiss Institute of Bioinformatics).
2.5. Quantification of Small Ruminant APOBEC3 Expression
Primer3 software (Version 4.1.0; Whitehead Institute for Biomedical Research, Cambridge
Cambridge, MA, USA) [22] was applied to design primers (Table 1) to amplify each of the four
A3 proteins (A3Z1, A3Z2, A3Z3 and A3Z2-Z3) nucleotide sequences described [18]. The additional
A3Z1 spliceoform lacking the deaminase motif (A3Z1Tr) was detected with new forward primer
(qA3Z1Tr-Fw3, Table 1) and maintaining the same reverse primer (qA3Z1-Rv). Quantitative RT-PCR
was performed with cDNA from ovine samples using SYBR Premix Ex Taq (Takara, Tokyo, Japan).
All samples were run in triplicate along with no template controls in an ABI Prism 7900 Sequence
Detector (Applied Biosystems, Foster City, CA, USA). β-actin was used as housekeeping gene for
relative quantification using the 2−∆Ct or 2−∆∆Ct method. Obtained values were compared with
non-parametric Mann-Whitney U Test (IBM SPSS Statistics for Windows, Version 23.0 IBM SPSS
Statistics. Armonk, NY, USA, IBM Corp.) and also using REST software (Qiagen, Hilden, Germany).
Standard curves of each PCR reaction were constructed by amplifying 10-fold dilutions of
plasmids containing each of the amplicons. The efficiency of each reaction was calculated as
E = (10(−1/slope) − 1) × 100 and compared.
2.6. In Vitro A3Z1/A3Z1Tr Expression
Kozak consensus sequence (GCCACC) was included in the forward primer and two extra stop
codons in the reverse (A3Z1-EcoRI-Fw and A3Z1-XhoI-Rv; Table 1) to amplify the complete ovine A3Z1
and the truncated isoform lacking deaminase motif (A3Z1Tr) using Assaf lung cDNA. The obtained
fragments were sub-cloned into the EXN eukaryotic expression vector kindly provided by Greg Towers
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(University College London, London, UK) (pLNCX2 with an inserted HA-tag; Clontech, Mountain
View, CA, USA) and sequenced. These constructions were used for transfection of TIGEF and 293T cells
with 1 µg of plasmid per well using Jet Prime (Polyplus, Illkirch, France) at a ratio of 1:2 (µg DNA:µL
Jet Prime reagent) according to the manufacturer’s instructions.
A3Z1 and A3Z1Tr mRNA detection in the transfected cells was carried out by full length RT-PCR
and relative expression quantified by quantitative RT-PCR.
2.7. Viral Infection
IFN-γ, IL-4 or control stimulated BDMs were infected with SRLVs (MVV and CAEV-like) at
0.1 TCID50/cell. On day 7 post infection, supernatants were collected for retrotranscriptase activity
(RT activity) quantification, performed with the HS-Lenti RT activity kit (Cavidi, Uppsala, Sweden)
according to the manufacturer’s instructions. The test was repeated at least three times in all
the experiments.
TIGEF transfected with A3Z1, A3Z1Tr and empty vector were infected with MVV-like SRLV at
0.5 TCID50/cell. In the interest of analyzing the activity of cellular A3Z1, clarified supernatants were
used 48 h post-infection for RT activity determinations, as indicated above. In parallel to RT activity,
virus titration of supernatants was also performed by Reed-Müench methodology.
HIV-1, MLV and Simian Immunodeficiency virus (SIV)-based pseudoviruses encoding green
fluorescent protein (GFP) were prepared in 293-T cells transfected with A3Z1, A3Z1Tr, A3Z2Z3 or
empty plasmid as described [16]. In addition, HIV-1 pseudoviruses carrying A3Z1 and A3Z2Z3
together with empty plasmid or A3Z1Tr were also prepared.
Cell culture supernatants containing HIV-1, MLV and SIV viral particles were harvested 2 days
after transfection, purified by centrifugation in a Megafuge 1.0 (Heraeus, Hanau, Germany) centrifuge
at 1800 rpm for 5 min and filtered through a 0.2-µm-pore-size membrane to remove any remaining
producer cell. The purified supernatants were placed on naive 293T cells (dilution 1:2 pseudovirus)
and the percentage of GFP positive cells was evaluated in a FACSCalibur (BD Biosciences, San Jose,
CA, USA) after 48 h. All the experiments were performed in triplicate.
2.8. Immunoblot and Immunoprecipitation
293T cells were co-transfected using Jet Prime with 1 µg of A3Z1-HA (N-terminal) and increasing
amounts of A3Z1Tr-HA (N-terminal) tagged proteins. Cell lysates were collected in Laemmli buffer
(0.125 mM Tris (pH 7.5), 4% SDS, 4% glycerol, 1% 2-mercaptoethanol) and proteins were separated by
SDS-PAGE (12% self-casted gels) and transferred onto nitrocellulose membranes (0.45 µm; Amersham
Protan; GE Healthcare, Little Chalfont, UK). Membranes were blocked o/n at 4 ◦C or 1 h RT with
PBS-T (20 mM Tris, 150 mM NaCl, 0.1% Tween 20) containing 5% non-fat dry milk. Anti-HA tag
antibodies (rat monoclonal antibody, Roche, Basel, Switzerland) were diluted 1:500 in blocking buffer
and incubated for 90 min. The chemiluminescence reaction (Super Signal West Dura, Thermo Scientific)
was revealed in Gene Genius Bio Imaging System (G-BOX Chemi HR16, Syngene, Cambridge, UK).
A3 degradation by Vif was evaluated in 293-T cells co-transfected using Jet Prime with 1 µg of HA
(N-terminal)-tagged A3Z1, A3Z1TR or A3Z2Z3 in EXN plasmid and 1 µg HA (C-terminal)-tagged Vif
in pVR1012 plasmid. Cell lysates were harvested and immunoblotting was performed using anti-HA
tag antibodies as described above.
For immunoprecipitation (IP), 293-T cells were co-transfected using Jet Prime with 1 µg of HA
(N-terminal)-tagged A3Z1 EXN and FLAG (N-terminal)-tagged A3Z1Tr pN3 plasmids. After 48 h,
lysates were collected and 10% of cell lysates were saved as an input control. Beads anti-FLAG
(EZ view Red Anti-FLAG Affinity Gel, Sigma-Aldrich, Saint Louis, MO, USA) were washed 3 times
(1 min each wash) with 500 µL of lysis buffer (Tris-HCl 50 mM, NaCl 500 mM, EDTA 1 mM,
2-mercaptoethanol 1 mM, Glycerol 5%, Triton 1% and NP40 1% at pH 7.5). Cell lysates were pre-cleared
with beads conjugated to anti-FLAG antibodies and incubated for 16 h at 4 ◦C. After washing in lysis
buffer, immunoprecipitated complexes were followed by SDS–polyacrylamide gel electrophoresis
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(PAGE) and immunostaining using anti-HA and anti-FLAG antibodies (mouse monoclonal anti-FLAG
M2-Peroxidase antibody, Sigma-Aldrich, Saint Louis, MO, USA). Reverse immunoprecipitation using
FLAG (N-terminal)-tagged A3Z1 pN3 and HA (N-terminal)-tagged A3Z1Tr EXN plasmids was also
carried out. β-tubulin immunoblots were used as loading control.
Vif immunoprecipitation was evaluated on 293-T co-transfected using Jet Prime with 1 µg of
FLAG (N-terminal)-tagged A3Z1 and A3Z1Tr pN3 plasmid and HA (C-terminal)-tagged Vif-pVR1012
plasmids. After 48 h, cell lysates were immunoprecipitated with beads conjugated to anti-FLAG
antibodies (Sigma-Aldrich, Saint Louis, MO, USA) as described above. Reverse immunoprecipitation
(IP) experiments using HA (N-terminal)-tagged A3Z1 and A3Z1Tr EXN and FLAG (N-terminal)-tagged
Vif-pN3 plasmids were carried out.
2.9. Lentiviral Incorporation of A3Z1
Supernatants containing MVV-like and CAEV-like SRLVs obtained after a passage in TIGEF
expressing A3Z1, A3Z1Tr and empty plasmid were harvested 2 days after infection, precleared by
centrifugation in a Megafuge 1.0 (Heraeus, Hanau, Germany) centrifuge at 800× g, for 10 min and
filtered through a 0.2-µm filter. Cell lysates were also obtained in Laemmli buffer. Virions were purified
by gradient centrifugation through 20% sucrose for 5 h at 10,000× g in an SW32 Ti rotor (Beckman
Coulter, Brea, CA, USA). Viral supernatants filtered and pelleted were resuspended in 100 µL of cold
PBS. Protein content in purified virions was measured by Bradford assay (Biorad, Hercules, CA, USA)
and A3Z1/A3Z1Tr incorporation into virus-like particles was checked. Immunoblots were developed
with anti-HA antibodies.
HIV-1 vector expressing GFP was produced in human 293-T cells co-expressing HA-tagged A3Z1
and A3Z1Tr and supernatants were purified and probed as above.
SRLV packaging plasmid (pCAEV-AP) based on CAEV-Cork [23] (encoding alkaline phosphatase),
kindly provided by Dr. Isidro Hötzel, was co-transfected in 293-T cells together with plasmids (pMDG)
encoding envelope protein from vesicular stomatitis virus (VSV-G) as described [24]. 293-T cells were
previously transfected with HA-tagged A3Z1, A3Z1Tr and empty plasmid resulting in the formation
of CAEV based viral particles expressing AP pseudotyped with VSV-G protein. Pelleted viruses were
purified and probed as above to check A3Z1 and A3Z1Tr incorporation.
2.10. Hypermutation
For hypermutation studies, SRLVs were produced in ovine skin fibroblast cells previously
transfected with 1 µg of HA-(N-terminal) A3Z1, A3Z1Tr or empty vector per well using Jet Prime.
The purified supernatants were placed on fresh permissive ovine skin cells. After 16 h, target cells were
harvested and DNA was extracted using DNA Blood Mini Kit (E.Z.N.A, Omega Bio-tek, Norcross, GA,
USA) and a region of the gag-pol genes was amplified (LTR-Fw-SP33; Table 1), cloned into pJET Cloning
(Thermo, Waltham, MA, USA) and sequenced with pJET-Fw primer. Sequence analysis including
gag region was conducted using Hypermutation 2.0 software (https://www.hiv.lanl.gov/content/
sequence/HYPERMUT/hypermut.html, Los Alamos National Laboratory, Los Alamos, NM, USA).
3. Results
3.1. APOBEC3 Expression in Monocytes and Blood Monocyte-Derived Macrophages (BDM)
Since monocytes are less permissive than macrophages to SRLVs replication, mRNA relative
expression of ovine A3 proteins (A3Z1, A3Z2, A3Z3 and A3Z2-Z3) was analyzed in these two cellular
subsets by using quantitative RT-PCR. Efficiency values calculated for each standard curve ranged
between 90% and 110%.
APOBEC3 mRNA expression levels in monocytes and in blood-derived macrophages (BDM) were
invariant in the case of A3Z2, A3Z3 and A3Z2-Z3. In contrast, A3Z1 mRNA expression levels were
highly increased in monocytes (Figure 1A).
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BDMs stimulated with hallmark cytokines of the M1 (IFN-γ) pattern of differentiation also showed
significant differences in A3Z1 expression but not in A3Z2, A3Z3 or A3Z2Z3 (Figure 1B). IL-4 treatment
did not induce A3 expression in BDM, showing values close to the control (p = 0.846), whereas IFN-γ
stimulation strongly induced A3Z1 expression (p < 0.001). IFN-γ or IL-4-stimulated BDM showed
completely different permissiveness to SRLVs replication. IL-4 and control stimulated cells showed
high RT activity values for both MVV-like and CAEV-like strains assayed. However, viral RT activity
in IFN-γ stimulated BDM was strongly inhibited (p < 0.001) (Figure 1C) along with an induction of
A3Z1 expression (Figure 1B). MR and DC-SIGN were induced in the permissive M2 subpopulation
confirming previous results [8]. A3Z1, MR and DC-SIGN expression did not modify after SRLV
infection of macrophages (Figure 1D).
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Besides the expected full sequence, other A3Z1 mRNA variants were also amplified and sequenced
from the same RT-PCR reactions (GenBank: KM266653 to KM266660). Among them, a 420 nucleotide
length amplicon was the most abundant and was present in all the samples used in the study
(Figure 2A). This A3Z1 isoform presented an alternative splicing between nucleotides 141 and 280 of
the coding sequence (amino acids 47 to 94, exon 3), corresponding to a shorter protein that lacks the
entire cytidine deaminase domain and the zinc finger motif, hereafter named truncated A3Z1 (A3Z1Tr)
(Figure 2B).
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Figure 2. A3Z1 and A3Z1Tr detection. (A) plification of complete A3Z1 and the A3Z1Tr spliced
variant from cDNAs samples of Assaf and Rasa Aragonesa sheep breeds; (B) ovine A3Z1 spliced
variant diagram compared to the GenBank deposited sequence. Introns are represented by solid lines,
exons by boxes and splicing sites by dotted lines. Untranslated regions, black; coding regions, white;
cytidine deaminase motif, dark grey; frameshift, light grey; and dotted line boxes: no translated;
(C) expression of A3Z1 and A3Z1Tr (2−∆Ct × 100) in BDM treated with IFN-γ, IL-4 or pN3- control for
6 days; (D) relative expression of A3Z1Tr (2−∆Ct × 100) in BDM infected with SRLVs from MVV-like
0.1 MOI. Values are the median (±interquartile range) of at least three independent experiments,
significantly higher (* p < 0.05; ** p < 0.01) (paired Mann-Whitney U Test).
IFN-γ, IL-4 and control stimulated macrophages were analyzed for their A3Z1 and A3Z1Tr
expression. As shown above, A3Z1 express on was higher i IF -γ stimulated BDM compared with
IL-4 and control BDMs. A3Z1Tr wa significa tly induced in IFN-γ and not in IL-4 or control BDMs
(Figure 2C). SRLV i fection also resulted in increased A3Z1Tr expression (Figure 2D) in contrast to
A3Z1, which was not altered (Figure 1D).
3.2. A3Z1-A3Z1Tr Interaction
Co-expression xperiments were carried out in 293-T cells by transfection plasmids encoding
A3Z1-HA and increasing quantities of A3Z1Tr-HA without altering protein expression (Figure 3A).
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Figure 3. APOBEC3Z1 expression and interaction. (A) HA-tag detection in 293T cells transfected
with 1 µg of A3Z1 and increasing amounts of A3Z1Tr; (B) 293T cells were co-transfected with
plasmids expressing A3Z1 tagged with HA and A3Z1Tr tagged with FLAG epitopes and after 48 h
were immunoprecipitated with anti-FLAG beads. Input lysates and co-immunoprecipitated samples
(IP) were immunoblotted by anti-HA or anti-FLAG monoclonal antibodies; (C) reverse pull-down
experiment. 293T cells were co-transfected with A3Z1-FLAG and A3Z1Tr-HA epitopes and after 48 h
were immunoprecipitated with anti-FLAG beads. Input lysates and co-immunoprecipitated samples
(IP) were immunoblotted by anti-HA or anti-FLAG monoclonal antibodies. β-tubulin blot was used as
loading control.
Using A3Z1Tr-FLAG protein and following anti-FLAG pull-down, anti-HA WB revealed the
interaction between A3Z1 an A3Z1Tr (Figur 3B). R verse pull-down experiments also sh wed
interaction between the ative and the truncated protein (Figure C).
3.3. Incorporation into Viral Particles
Since restriction may be dependent on deaminase activity in this is in turn dependent on A3
encapsidation into virions [25], we wanted to know whether A3Z1 could also be incorporated into
virions. Transfected TIGEF and 293T cell lysates showed high amounts of A3Z1 and A3Z1Tr (Figure 4).
Both HA-tagged proteins were evident in MVV-like purified viruses produced in infected TIGEF cells
(Figure 4, upper panel) and also in CAEV-AP produced in 293T cells. Incorporation was also effective
in co-transfected cells. A3Z1 and A3Z1Tr were also incorporated into HIV-1 particles very efficiently
(Figure 4). Produced viral vectors were further used to transduce 293T cells in which no difference in
infectivity was observed among A3Z1, A3Z1Tr or EXN containing viruses (p > 0.05 for all cases).
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3.4. Vif Degradation 
Despite efficient incorporation into virions, A3Z1 and A3Z1Tr were resistant to Vif degradation 
(Figure 5A, upper and middle panels) compared to A3Z2Z3 that was used as control (Figure 5A, 
lower panel). Interestingly, immunoprecipitation experiments showed Vif interaction with both 
A3Z1 and A3Z1Tr proteins (Figure 5B,C). Despite faint expression, A3Z1Tr-FLAG presence was 
confirmed in overexposed images and in WB in which the truncated protein was loaded alone, 
however, for the sake of a neat presentation of the results, overexposed images have been omitted. 
Figure 4. APOBEC3 encapsidation into SRLVs and HIV-1 virions. A3Z1, A3Z1Tr, empty plasmid and
A3Z1/A3Z1Tr were transiently expressed in TIGEF and 293T cells, that were respectively infected with
MVV-like SRLV or transduced with a CAEV-like pseudovirus (CAEV-AP) and a HIV-1 viral vector.
Seven days post infection cleared supernatants were pelleted on sucrose gradient. Purified viruses and
whole cell lysates (WCLs) and were blotted against HA. β-tubulin blot was used as loading control.
3.4. Vif Degradation
Despite efficient incorporation into virions, A3Z1 and A3Z1Tr were resistant to Vif degradation
(Figure 5A, upper and middle panels) compared to A3Z2Z3 that was used as control (Figure 5A, lower
panel). Interestingly, immunoprecipitation experiments showed Vif interaction with both A3Z1 and
A3Z1Tr proteins (Figure 5B,C). Despite faint expression, A3Z1Tr-FLAG presence was confirmed in
overexposed images and in WB in which the truncated protein was loaded alone, however, for the
sake of a neat presentation of the results, overexposed images have been omitted.Viruses 2017, 9, 345 11 of 19 
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Figure 5. APOBEC3 resistance to MVV Vif. (A) HA-tag detection after 48 h in 293T cells co-transfected
with 1 µg of plasmids expressing A3Z1 (upper panel), A3Z1Tr (middle panel) or A3Z2Z3 (down
panel) with different concentrations of Vif plasmid; (B) 293T cells were co-transfected with plasmids
expressing Vif-HA tagged and A3Z1Tr or A3Z1 tagged with FLAG epitopes and after 48 h were
immunoprecipitated with anti-FLAG beads. Input lysates and co-immunoprecipitated samples
(IP) were immunoblotted by anti-HA or anti-FLAG monoclonal antibodies; (C) reverse pull-down
experiment, 293T cells were co-transfected with plasmids expressing Vif tagged with FLAG and A3Z1Tr
or A3Z1 tagged with HA epitopes and after 48 h were immunoprecipitated with anti-FLAG beads.
Input lysates and co-immunoprecipitated samples (IP) samples were immunoblotted by anti-HA or
anti-FLAG monoclonal antibodies. β-tubulin blot was used as loading control. IP: Immunoprecipitation.
INPUT: Input sample.
3.5. APOBEC3Z1 Restriction of Retrovirus Infection
Restriction was first evaluated in 293-T producer cells transfected with A3Z1 together with
plasmids for the production of Vif-competent HIV-1, MLV or SIV GFP-encoding vectors. Retroviral
produced particles transduced from 15 to 32% less 293-T cells when A3Z1 was incorporated. A3Z1Tr
despite efficient incorporation into lentiviral particles did not inhibit the retroviral cycle. A3Z2Z3
induced the highest degree of retroviral inhibition in this cellular system with a 50% resistance against
HIV-1 as previously described (Figure 6A) [26,27].
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lower (* p < 0.05; ** p < 0.01; *** p < 0.001) compared to empty plasmid; paired Mann-Whitney U
Test); (B) relative infectivity of HIV-1 pseudoviruses produced in presence of A3Z1 and A3Z2Z3
supplemented with empty plasmid (control) or A3Z1Tr (spliced variant). Data are relative to the
infectivity obtained with empty plasmid (discontinued line). Values are the median (±interquartile
range) of at least three independent experiments, significantly lower (* p < 0.05) compared to empty
plasmid; paired Mann-Whitney U Test); (C) RT activity values (pg/mL) upon MVV-like infection in
TIGEF (0.5 MOI) expressing A3Z1, A3Z1Tr, empty plasmid and control cells (upper panel). HA-tag
detection after 48 h post transfection (lower panel). Values are the median (±interquartile range) of at
least three independent experiments, significantly lower (* p < 0.05) paired Mann-Whitney U Test.
In the case of HIV-1, co-expression of A3Z1Tr and A3Z1 in the same virus producer cells
significantly modified viral production since restriction was relieved. In contrast, A3Z1Tr expression
did not modify the inhibition exerted by A3Z2Z3 (Figure 6B).
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As in the human case [28], attempts to permanently express A3Z1 in SRLVs-permissive cells
resulted in aberrant cells inappropriate for the restriction experiments. Antiviral properties of A3Z1
and A3Z1Tr were finally evaluated by transient transfection in TIGEF cells, in which HA-tagged A3Z1
and A3Z1Tr protein expression was detectable by Western blot (WB) (Figure 6C, lower panel). After
infection with SRLVs, TIGEF-Z1 cells showed significantly lower RT activity values as compared
to TIGEF-A3Z1Tr cells, TIGEF-empty plasmid cells and also compared to control cells (p < 0.05)
(Figure 6C, upper panel). Titration of SRLVs in cell supernatants by the Reed-Muench method revealed
that secreted virions were infective, resulting in viral titer values in line with RT activity results.
3.6. A3Z1 DNA Hypermutation Activity
Permissive skin fibroblasts, with negligible endogenous A3Z1 expression, were infected with A3Z1
or A3Z1Tr containing SRLVs, and viral sequences obtained. Sequences spanning the gag gene indicated
a high G to A mutation rate, in the GA→AA context, after infection by MVV-like containing A3Z1
(Figure 7). It can thus be concluded that the target sequence for ovine A3Z1 is GA-AA. Interestingly,
G to A mutations in this context were also found in A3Z1Tr or empty plasmid transfected cells,
as compared to sequences from untransfected cells, where no mutation was found in five clones.
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Figure 7. Nucleotide context of deamination. G to A mutations average in gag sequences obtained
from ovine skin fibroblast (OSF) infected with SRLVs produced in OSF expressin A3Z1, A3Z1Tr or
empty plasmid. Edited clones (A3Z1 n = 7, A3Z1Tr n = 9, Em ty plasmid n = 7) in gag gene were
aligned and analyzed with the Hypermut 2.0 program (https://www.hiv.lanl.gov/content/sequence/
HYPERMUT/hypermut.html, Los Alamos National Laboratory, Los Alamos, NM, USA).
3.7. A3Z1/A3A Sequence Analysis
Next, we studied the presence of A3Z1 and A3Z1 truncated isoforms in different primate species
susceptible to lentivirus infection. A3Z1 sequences were successfully amplified from lung samples
of the Rasa Aragonesa and Assaf sheep breeds and from PBMC of a Murciano-Granadina goat using
primers located in the 5′ and 3′-UTRs. The 558 nucleotide coding sequence-CDS sequence analysis
revealed a high similarity (0.971 for sheep and 0.967 for goat samples) between the obtained sequences
and the one deposited in GenBank (GenBank: NM_001161379). These similarities were slightly lower
when analyzing deduced amino acid sequences (0.930 and 0.935 for sheep and 0.908 for goat samples).
Spanish sheep samples showed an amino acid deletion at position 134, whereas goat samples presented
a different deletion at position 31, within a non-conserved region between sheep and goats. None
of these deletions affected the cytidine deaminase motif, which was conserved region encompassing
amino acids 57 to 95 (H-X-E-X23-28-P-C-X2-4-C). Both, sheep and goat sequences, also conserved a
zinc finger C2H2-type domain between residues 88 and 108 overlapping with the cytidine deaminase
motif. Kozak sequence context surrounding the A3Z1 M1 initiation codon was adequate [29].
Viruses 2017, 9, 345 14 of 19
Macaca fascicularis A3A sequences consisted of 609 nt and were quite divergent between the
two individuals analyzed, with 19 variations in the nucleotide sequence and 11 amino acid changes.
Truncated isoforms were also present specifically, an A3A 455 nt isoform that was only amplified from
one of the samples (GenBank: KM266650 to KM266652).
Specific human A3A amplification, homologous to sheep A3Z1 protein, yielded non-specific
amplicons when HTB-54, BEAS-2B, HEP-B2 or Caco-2 cultured cell lines were used as cDNA source.
Successful amplification was achieved from four human PBMC and the obtained sequence was
identical to the deposited in GenBank (GenBank: NM_001193289). Besides the deduced amino acid
sequence with one cytidine deaminase domain between amino acids 70 to 110, shorter isoforms were
also observed (Figure 8B) (GenBank: KM266646 to KM266649). Specifically, three different sized
spliceoforms: (i) 546 nt, resulting in an 18 amino acid shorter protein with alternative splicing located
between nucleotides 29 and 84 (amino acids 11 to 28, corresponding to exon 2), the cytidine deaminase
domain remained intact and the methionine at position 13 was absent. (ii) 525 nt, lacking the cytidine
deaminase domain due to an alternative splicing that produces a 25 amino acid deletion at position
59 to 83, corresponding to exon 3. (iii) 455 nt, with alternative splicing from nucleotides 29 to 175,
which comprises the entire exon 2, that changes the frame at amino acid 11 encoding a 71 amino acid
long non-characterized protein lacking also the cytidine deaminase domain.Viruses 2017, 9, 345 15 of 19 
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4. Discussion
SRLVs replication occurs at low levels but at a constant rate leading to immune dysfunction and
disease development in a process accomplished in years. However, in some cell types (i.e., monocytes)
or under some circumstances (i.e., pregnancy), lentivirus replication can be naturally modulated [30–32]
potentially providing clues for the designing of new therapeutic targets. Among proteins interfering
the viral replication cycle, restriction factors of the innate immunity are becoming an attractive strategy
to control infection spread. Specifically, tripartite motif-containing protein 5 (TRIM5α) and A3Z2Z3
have been recently described in small ruminants with promising results in restricting homologous as
well as heterologous lentiviral infection [19,33].
In the present study, we explored ovine A3Z1 restriction properties against homologous viruses
(SRLVs) in the context of macrophage maturation depicting the mechanisms involved and investigating
Vif involvement as well as restriction against heterologous viruses (HIV-1). In addition to full-length
A3Z1, transcriptional analysis revealed the presence of additional spliceoforms lacking the entire
cytidine deaminase motif (A3Z1Tr) indicating that A3Z1 isoforms lacking the deaminase motif are
naturally present.
SRLVs replication is induced when maturation from monocyte into macrophages takes
place [12,34] presumably due to the induction of transcription factors needed for viral protein
expression. Additionally, as shown here, A3Z1 expression was dramatically reduced in BDM as
compared with parental monocytes likely contributing to viral restriction observed in the latter. In line
with our results, decreased A3A expression during monocyte to macrophage differentiation has been
associated with resistance to HIV-1 [7,28], indicating the presence of a conserved restriction mechanism
among mammals susceptible to lentivirus infection.
Ovine M1-macrophages obtained upon stimulation with IFN-γ were resistant to SRLVs infection
and presented high levels of A3Z1 mRNA (this study and [8]), whereas M2 susceptible to SRLVs
infection, showed low A3Z1 levels, positioning A3Z1 in the SRLVs (MVV and CAEV-like) restriction
pathway. A3Z1Tr was also induced upon BDM stimulation with cytokines or SRLVs infection
suggesting a role in immune activation.
Viral restriction was cell type dependent since A3Z1-expressing TIGEF, with similar A3Z1
mRNA levels to M1 macrophages, faintly restricted the replication of SRLVs Vif-competent strains.
Similarly, A3A restriction of HIV has been demonstrated in myeloid but not in cells from other
lineages [7,28,35,36].
In addition, although A3Z1 restriction compared to A3Z1Tr in vitro was likely dependent on the
deaminase activity, since deaminase motif was not present in A3Z1Tr, hypermutation was also found
in viruses obtained after infection of cells expressing A3Z1Tr or the empty plasmid. In this regard,
human A3A is induced by interferon following administration of foreign DNA by transfection [37].
Whether the induction of endogenous A3Z1 proteins in TIGEF transfected with plasmids is covering
up real A3-derived effect is now under investigation.
Little information limited to humans is available regarding A3 splicing variants and their influence
on restriction. A3G truncated forms, which are expressed at much lower levels than native protein,
do not interact with Vif and lack antiviral activity [38]. A3H splicing variants have different antiviral
activities depending on protein expression [39]. A3F splicing variants despite being highly expressed
and conserving cytidine deaminase activity, differ in their sensitivity to viral Vif and are incorporated
into viral particles less efficiently than full protein, thereby displaying decreased antiviral activity [38].
Alternatively, spliced truncated isoforms may be a mechanism to reduce the amount of full-length
proteins [40]. Here we have determined different splicing rates of A3Z1 depending on the stimulus on
macrophages, being immunological stimulation of BDM with IFN-γ and more significantly SRLVs
infection, inducers of the spliced protein. This was also found in THP-1 PMA-derived macrophages
in which A3ATr expression was induced upon transduction with different retroviral vectors such as
HIV-1 or MLV-B/N.
Viruses 2017, 9, 345 16 of 19
Efficient co-expression in 293T cells enabled interaction experiments demonstrating
co-immunoprecipitation of A3Z1 and A3Z1Tr. This interaction could alter full-length protein
function suggesting a possible regulation mechanism consisting in binding and negative dominance,
as described in the case of MYD88s [41]. Indeed, A3Z1Tr relieved the restriction observed against
HIV-1 when co-expressed with A3Z1, but did not alter the restriction exerted by the divergent A3Z2Z3.
However, the presence of A3Z1Tr did not influence the SRLVs restriction observed in M1-macrophages
obtained upon IFN-γ induction.
A3Z1 lentiviral restriction was likely independent on the presence of viral Vif since transduction
(HIV-1) and infection (SRLVs) with Vif-competent viruses was affected. This could argue for the
presence of extra elements needed for the Vif-APOBEC3Z1 interaction, which were not present in the
culture conditions used here [42]. Transcription factor CBFβ, as well as viral RNA, is necessary to
form the bridge between primate A3 proteins and Vif [26]. Recently, SRLVs Vif has been described to
follow alternative mechanisms to degrade A3 using CypA as cofactor [26,27]. Whether A3Z1 follows
the same pathway in Vif degradation co-expression experiments is unknown. On the other hand,
significant amounts of A3G have been detected in Vif-competent HIV virions produced in 293T cells,
clearly showing that under certain circumstances, Vif does not lead to complete depletion of A3 [16,43].
Interestingly, and in contrast to A3A [28] both A3Z1 and A3Z1Tr were efficiently incorporated into
SRLVs (MVV and CAEV-like) and HIV viral particles bypassing Vif-mediated degradation.
The long interaction between lentiviruses and their hosts has led to the idea that inter-species A3,
evolved under the pressure of a divergent Vif, could be good candidates to face human lentiviruses.
Following this model, ovine A3Z2-Z3 and A3Z3 proteins are able to restrict HIV-1 irrespective of
HIV-Vif expression by deaminase dependent and independent pathways. Interestingly, Vif from
SRLVs is able to efficiently degrade human, macaque, cow and cat’s A3Z3 [17,19]. In this study, A3Z1
restricted HIV-1 in 293-T producer cells (Figure 6A). However, experiments have not been conducted
in myeloid cells which could be the proper cell type to test A3Z1/A3A restriction profile.
The overall A3A deaminase activity in vivo is likely determined by a complex balance between
stimulatory and inhibitory pathways, truncated isoforms being one of such potential elements assuring
viral defense while minimizing host DNA deleterious effects [44]. Increased functional diversity
may have implications in expression regulation, antiviral activities, Vif resistance, etc., all of them
influencing the design of new therapeutic measures as well as in the development of tumorigenic
processes in which cytidine deaminases are relevant.
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